Anti-Human CD133/PROM1 & CD3E Bispecific Antibody (BOU355) is a research-grade recombinant antibody targeting CD133. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.